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Proteomic characterization of carbonylated amino acid sites currently relies on confidently
matching tandem mass spectra (MS2) to peptides within a sequence database. Although
effective to some degree, reliable proteomic characterization of carbonylated peptides using
this approach remains a challenge needing new, complementary solutions. To this end, we
developed a method based on partial 18O-labeling of reactive carbonyl modifications, which
produces a unique isotope signature in mass spectra of carbonylated peptides and enables
their detection without reliance on matching MS2 spectra to a peptide sequence. Key to our
method were optimized measures for eliminating trypsin-catalyzed incorporation of 18O at
peptide C-termini, and for stabilizing the incorporated 18O within the carbonyl modification to
prevent its loss during liquid chromatography separation. Applying our method to a rat
skeletal muscle homogenate treated with the carbonyl modification 4-hyroxynonenal (4-HNE),
we demonstrated its compatibility with solid-phase hydrazide enrichment of carbonylated
peptides from complex mixtures. Additionally, we demonstrated the value of 18O isotope
signatures for confirming HNE-modified peptide sequences matched via sequence database
searching, and identifying modified peptides missed by MS2 and/or sequence database
searching. Combining our 18O-labeling method with a customized automated software script,
we systematically evaluated for the first time the efficiency of MS2 and sequence database
searching for identifying HNE-modified peptides. We estimated that less than half of the
modified peptides selected for MS2 were successfully identified. Collectively, our method and
software should provide valuable new tools for investigators studying protein carbonylation
via mass spectrometry-based proteomics. (J Am Soc Mass Spectrom 2010, 21, 1190–1203) ©
2010 American Society for Mass SpectrometryThe post-translational introduction of reactive ke-tone and aldehyde moieties into proteins, knownas protein carbonylation, is a classic marker of
oxidative stress that correlates well with both the aging
process itself as well as various age-associated diseases,
ranging from Alzheimer’s disease and Parkinson’s dis-
ease to amyotrophic lateral sclerosis and diabetes [1].
While a definitive role in disease etiology has yet to be
established, the deleterious effect carbonylation has on
protein function provides a putative biochemical mech-
anism through which this irreversible modification may
contribute towards the initiation and propagation of
disease [2]. To further characterize the basic biology of
protein carbonylation and thus better define its poten-
tial pathologic role, the specific proteins and amino
Address reprint requests to Dr. T. J. Griffin, Department of Biochemistry,
Molecular Biology, and Biophysics, University of Minnesota, Minneapolis,
MN 55455, USA. E-mail: tgriffin@umn.edu
© 2010 American Society for Mass Spectrometry. Published by Elsevie
1044-0305/10/$32.00
doi:10.1016/j.jasms.2010.03.029acids carbonylated throughout disease progression
need to be identified [2].
Characterizing protein carbonylation on a proteome-
wide scale is a core objective in the emerging field of
redox proteomics, which seeks to characterize proteins
susceptible to oxidative or nitrosative modifications [3].
Tandem mass spectrometry (MS2)-based proteomics
enables both the identification of carbonylated proteins
and the localization of the corresponding carbonyl to a
specific amino acid, thus providing a powerful tool in
redox proteomics. However, such studies for protein
carbonylation are not routine, as several challenges
complicate the process.
One challenge is due to the complexity of carbonyl
modifications, which involves a number of mechanisms
generating various chemically unique reactive carbon-
yls of differing masses that target several amino acids.
For example, carbonyls may be directly introduced into
the side chains of Lys, Arg, Pro, and Thr via metal
catalyzed oxidation, and into the side chain of Glu and
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backbone [4, 5]. Alternatively, reactive carbonyl inter-
mediates derived from protein glycation and lipid per-
oxidation target the side chains of Lys and Arg, and
Cys, His, Lys, and Arg, respectively [6–9]. Importantly,
most of these reactive carbonyl moieties (in the form of
aldehydes or, to a lesser extent, ketones) retain their
reactivity following conjugation, and are thus suscepti-
ble to subsequent Schiff-base bond formation.
Another challenge lies in the relatively low abun-
dance of carbonylated proteins within complex biolog-
ical mixtures. To address this challenge, front-end en-
richment methods that target this substechiometric
protein population have been developed. Primarily,
these methods rely on covalent chemistry-based enrich-
ment methods exploiting the reactivity of hydrazides
with reactive carbonyls, enabling the global analysis of
carbonylated proteomes [2]. One common approach is
to enrich carbonylated proteins labeled with reagents
such as biotin-hydrazide, or variations thereof, via
avidin-affinity chromatography before their identifica-
tion by mass spectrometry. This approach has proven
useful for characterizing the carbonyl proteomes of
various mammalian-derived protein lysates generated
from plasma [10], tissue homogenates [11–13], mito-
chondrial extracts [14], and tissue-derived cell lines
[15, 16]. An important caveat regarding the biotin-
hydrazide approach is that carbonylation of the proteins
identified is inferred based on their enrichment by
avidin alone, as the specific carbonylated residue is very
rarely identified due to signal suppression from the
remaining non-carbonylated peptides in the sample.
Also, biotin-hydrazide itself readily fragments into a
number of abundant ions, which can preclude identifi-
cation of biotin-hydrazide labeled peptides [17].
Efforts to unequivocally identify sites of carbonyla-
tion to specific residues have thus relied on methods for
enriching carbonylated peptides, followed by MS2 anal-
ysis and matching to peptide sequences via automated
sequence database searching. One promising approach,
involving the avidin-affinity enrichment of biotinylated
peptides, rather than labeled proteins, has been used to
successfully localize sites of carbonylation within both
simple and complex protein mixtures [18, 19]. How-
ever, the aforementioned fragmentation of biotinylation
reagents in MS2 spectra and increased hydrophobicity
from the label complicate this method [17].
As an alternative to label-based enrichment ap-
proaches, we developed a label-free solid-phase hydra-
zide (SPH) reagent that directly and reversibly captures
carbonylated peptides via formation of Schiff-base
bonds [20], and demonstrated its utility on a complex
mixture of HNE-modified proteins. Importantly, cap-
tured peptides are released from the reagent by hydro-
lyzing the Schiff-base, and are thus restored to their
native form as the carbonyl is replenished. While this
label-free method eliminated fragment ions in the MS2
spectra derived from a biotinylating reagent, we ob-
served that many seemingly high quality MS2 spectra,for unknown reasons, still did not confidently match to
HNE-modified peptide sequences.
Based on these collective observations concerning
the challenges of identifying carbonylated peptides,
new methods to assist in their detection and identifica-
tion are needed. Here we have sought to develop a
method by which enriched, carbonylated peptides
could be unambiguously detected by mass spectrome-
try, without a dependence on successfully matching
their MS2 spectra to sequences via database searching.
Such a method would have potential value in: (1)
confirming the presence of carbonylated peptides that
are matched via database searching; (2) differentiating
enriched, carbonylated peptides from noncarbonylated
background peptides, which could then be further
targeted for MS2 analysis; and (3) evaluating the effi-
ciency by which these peptides are identified by MS2
and facilitating studies for improving their MS2-based
identification.
Our method takes advantage of the nonenzymatic
solvent exchangeable properties of reactive carbonyl
oxygens, enabling the partial incorporation of 18O into
carbonylated peptides and resulting in an isotope sig-
nature detected in MS or MS2 spectra unique to these
modified peptides. Using HNE-modified myoglobin as
a standard, and a HNE-modified complex protein mix-
ture derived from rat skeletal muscle, we have devel-
oped an optimized protocol for the specific and stable
incorporation of 18O into reactive carbonyls that com-
plements label-free enrichment methods and improves
the detection of carbonylated peptides. Our results
demonstrate the value of this method for confirming
putatively HNE-modified peptide sequences identified
from MS2 spectra, decreasing false negative identifica-
tions of such sequences, and providing a novel means to
assess the efficiency of the identification of these pep-
tides via MS2 and sequence database searching. As
such, our method provides a valuable new tool for
investigators endeavoring to study protein carbonyla-
tion via mass spectrometry-based proteomics.
Materials and Methods
Preparation of 18O-Labeled HNE-Modified
Myoglobin Digest
Five-hundred g of myoglobin from horse heart (Sigma-
Aldrich Corp., St. Louis, MO, USA) was treated with 2
mM 4-hydroxynonenal (HNE, Cayman Chemical Com-
pany, Ann Arbor, MI, USA) for 2-h at 37 °C in 100 mM
sodium phosphate, pH 7.2. The modified sample was
filter centrifuged using an Amicon Ultra spin column
with a 10 kD cutoff (Millipore, Billerica, MA, USA) to
remove excess HNE, and the resulting retentate was
reconstituted in 100 mM sodium phosphate, pH 7.2.
After measuring the protein concentration by the BCA
assay (Thermo Fisher Scientific Inc., Rockford, IL, USA),
the entire HNE-modified myoglobin sample was tryp-
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sequently stored at 20 °C for future experiments.
18O-labeling of HNE-Peptides
The following protocol for labeling HNE-modified pep-
tides with 18O was applied to a 2 g aliquot from the
HNE-modified myoglobin digest and to the enriched
peptide fraction from the HNE-modified rat skeletal
muscle tissue lysate. Lyophilized samples were recon-
stituted in 100 L of 18O-labeling buffer (70% vol/vol of
97% H2
18O (Sigma), 100 mM sodium phosphate, pH 7.2)
and then incubated at room-temperature for 2 h. Next,
a small volume of concentrated sodium hydroxide was
added to adjust the sample pH to about 8, followed by
the addition of alkaline sodium borohydride to a final
concentration of 10 mM. After incubating at room
temperature for an additional hour, the samples were
desalted by C18 ziptips and the resulting elates vacuum
centrifuged to dryness. To back-exchange any 18O mol-
ecules incorporated into peptide carboxylates during
labeling, each sample was reconstituted in 100 L
H2
16O supplemented with 1 g Trypsin, incubated at
room-temperature for 24 h, vacuum centrifuged to
dryness, and stored at 20 °C.
Comparing Methods for Eliminating the
Oxygen-Exchange Activity of Trypsin
One-hundred g of the HNE-modified myoglobin di-
gest was spiked with 2 additional g of trypsin and
divided into 20 g aliquots, each subjected to a different
method for depleting the oxygen-exchange activity of
trypsin. One 20 g aliquot was diluted to 1 mL with
water and filter centrifuged using an Amicon Ultra
filter spin column (10 kDa cutoff) per manufacturer’s
specifications. Following a single pass through the spin
column, the peptides in the flow-through fraction were
vacuum centrifuged to dryness and split into four
aliquots. The first aliquot was 18O-labeled according to
the protocol described above. The second aliquot was
vacuum centrifuged to dryness and subsequently re-
constituted in alkaline 18O-labeling buffer (supple-
mented with 100 mM sodium hydroxide, pH  12).
This sample was then reduced and processed for anal-
ysis according to the 18O-labeling protocol described
above. The third aliquot was boiled for 15 min before
labeling with 18O so as to denature the trypsin and thus
render it inactive. Seventy L of H2
18O and 10 L 1M
sodium phosphate, pH 7.2, was then directly added to
the boiled sample so as to establish 18O-labeling condi-
tions consistent with those used for the other methods.
Again, the sample was reduced and analyzed according
to the 18O-labeling protocol described above. A fourth
aliquot was 18O-labeled according to the protocol de-
scribed above without concern for 18O incorporation
into the C-terminus of peptides by trypsin-catalyzed
oxygen exchange. The reduced, 18O-labeled sample wasthen desalted by C18 ziptip and the eluate vacuum
centrifuged to dryness. The dried sample was subse-
quently reconstituted with 100 L of 100% H2
16O sup-
plemented with 2 g trypsin, incubated overnight at
room temperature, and vacuum centrifuged to dryness.
All 18O-labeled peptides from each aliquot were ana-
lyzed according to the MALDI-TOF protocol described
herein.
Preparation of HNE-Treated Lysate from Rat
Skeletal Muscle Tissue
Twelve-month-old, adult Fisher 344 rats were pur-
chased from the Minneapolis Veterans Administration
Rodent Colony, and fully accredited by the Association
for Assessment and Accreditation of Laboratory Ani-
mal Care International. The study was approved by the
University of Minnesota Institutional Animal Care and
Use Committee. Skeletal muscle tissue from both slow-
twitch (soleus) and fast-twitch (tibialis anterior) muscle
fibers were isolated from rat hind limb muscles. One-
and-a-half grams of combined muscle tissue was then
minced with scissors and washed thrice with ice-cold
1X PBS (Sigma) by pelleting the tissue each time at 200 g.
The final tissue pellet was reconstituted in Tissue
Lysis Buffer [1:10 wt/vol, 150 mM sodium chloride, 50
mM Tris-HCl pH 7.4, 1 mM EDTA, 1% Triton X-100, 1%
deoxycholic acid, 0.1% sodium dodecylsulfate, and 1
protease inhibitor cocktail (Roche)] and vortexed vigor-
ously for 20 s. Next, the tissue was homogenized using
a PowerGen tissue homogenizer (Thermo Fisher Scien-
tific Inc., Rockford, IL, USA) on the lowest setting with
two 20 s mixes. The cellular debris was then pelleted by
centrifuging the sample at 700  g for 10 min at 4 °C.
The supernatant was carefully removed and the pro-
teins extracted by methanol-chloroform precipitation as
previously described [14]. The resulting delipidated
protein pellet was reconstituted in 100 mM sodium
phosphate, pH 7.2, containing 0.1% SDS and quantified
by the BCA assay. HNE-modified proteins were then
generated by incubating 3 mg of the tissue lysate with
250 M HNE for 2 h at 37 °C. Excess HNE was
subsequently removed by filter centrifugation using an
Amicon Ultra (Millipore, Billerica, MA, USA) spin col-
umn (10 kD cutoff) per manufacturer’s instruction. The
retentate was diluted to 2 mL with trypsin friendly
buffer (100 mM sodium phosphate pH 7.2, 5 mM TCEP,
10% acetonitrile) and then digested overnight following
the addition of 60 g of trypsin.
Enrichment of HNE-Modified Peptides from
HNE-Treated Rat Skeletal Muscle Tissue Lysate
Carbonylated peptides within the HNE-treated tissue
lysate digest were enriched using UltraLink Hydrazide
Gel (Thermo Fisher Scientific Inc., Rockford, IL, USA), a
commercially available solid-phase hydrazide reagent
that is traditionally used for building antibody affinity
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washed with water in a 1.5 mL Eppendorf tube by
vortexing vigorously. The resin was then pelleted by
bench-top microcentrifugation, resuspended with 500
L of the sample digest buffer (100 mM sodium phos-
phate, pH 7.2), combined with the sample digest, and
mixed overnight on an Eppendorf Thermomixer R tube
shaker (1200 RPM, 25 °C). After spinning down the
resin, the non-bound peptides in the supernatant were
removed and saved for future analysis. The remaining
resin pellet was washed four times each with 1 mL of
1% SDS, 1M NaCl, 80% acetonitrile, and distilled water
by vigorous vortexing (20 s), and bench-top microcen-
trifugation in succession. To release the hydrazide-
bound peptides 1 mL of 1% acetic acid was added to the
washed resin and the mixture was incubated for two
hours on an Eppendorf Thermomixer R tube shaker
(1200 RPM, 25 °C). Importantly, 1% acetic acid proved
optimal for releasing UltraLink Hydrazide (Pierce)
bound peptides while minimizing the resin-derived
contaminants generated by stronger acidic conditions.
Such contaminates, although not specifically identified,
are manageable under these less acidic conditions such
that clean, database-searchable spectra can be obtained.
After spinning down the resin, the enriched peptides
present in the supernatant were collected and the resin
was washed 1 with an additional 300 L of distilled
water. The wash supernatant as added to the released
peptides and the combined solution was vacuum cen-
trifuged to dryness.
MALDI-TOF MS/MS
The lyophilized 18O-labeled HNE-treated myoglobin
digests were reconstituted with 1.5 L of MALDI sam-
ple buffer (80% acetonitrile, 0.1% trifluoroacetic acid),
mixed with -cyano-4-hydroxycinnamic acid matrix,
and spotted on a MALDI plate. Both full-scan and MS2
spectra were collected in the positive ion detection
mode on a Qstar XL quadrupole-TOF mass spectrometer
fitted with a MALDI ion source (Applied Biosystems Inc.,
Foster City, CA, USA). Spectra were generated using the
instrument parameters previously described [20].
LC-MS/MS
Enriched peptides from the HNE-treated rat skeletal
muscle tissue lysate were reconstituted in 5 L of
sample buffer (2% ACN, 0.1% formic acid, aqueous)
and fractionated by microcapillary liquid chromatogra-
phy (LC) using an Eksigent (Eksigent Technologies,
Dublin, CA, USA) nanoLC-1D plus HPLC. Specifically,
peptides were fractionated by reversed-phase using an
in-line analytical capillary column (100 m  13 cm)
packed in-house with Magic C18 resin (5 m, 200 Å
Magic C18 AG; Michrom BioResource, Auburn, CA,
USA). A linear gradient of 40% buffer B (80% ACN,
0.1% formic acid, aqueous) at a flow rate of 250 nL/min
over 60 min was used to electrospray peptides directlyinto a linear ion trap mass spectrometer equippedwith an
Orbitrap mass analyzer (LTQ-Orbitrap, Thermo Elec-
tron Corp., San Jose, CA, USA). A top five data-
dependent method incorporating a 30 s dynamic exclu-
sion window was used to continuously select the top
five most abundant precursor ions in the Orbitrap
(AGC target; 1  106 ions, resolution; 60,000, maximum
ion accumulation time; 500 ms, minimum threshold
intensity; 1000) for MS 2 fragmentation in the linear ion
trap (AGC target; 1  104, maximum ion accumulation
time; 100 ms, normalized collision energy; 35, precursor
isolation width; 2 m/z, microscan per spectrum; 1). Ions
carrying either singly or unassigned charges were ex-
cluded from MS2 fragmentation.
Database Searching and Data Analysis
All MS2 data files extracted from the RAW file for
the HNE-modified rat skeletal muscle sample were
searched using the SEQUEST algorithm (ver. 27, rev.12,
Thermo Fisher Scientific Inc., Rockford, IL, USA)
against a concatenated R. norvegicus database (Refseq,
Release 22, March 5, 2007), containing a composite
77,763 protein sequences. A number of variable modi-
fications were specified in the search parameters includ-
ing the oxidation of methionine (15.9949), the addition
of 18O-labeled and reduced HNE (160.1349) to Cys,
His, and Lys residues, and the incorporation of one 18O
molecule into the peptide C-terminus (2.0042). Mass
tolerances of 0.8 Da and 1.0 Da were used for the
precursor and fragment ions, respectively, and a par-
tially tryptic constraint was applied. A statistical mea-
sure of confidence was assigned for all prospective
database matches via the Peptide Prophet scoring algo-
rithm, and the resulting data were evaluated and orga-
nized using Scaffold (ver. 2_02_03; Proteome Software,
Portland, OR, USA). To obtain a high confidence data-
set, an 8 ppm mass accuracy constraint was applied to
the subset of spectra matching to carbonylated pep-
tides, which resulted in zero hits to the reverse data-
base. This dataset was subsequently used to compare
against the number of spectra containing 18O isotope
signatures as detected by our software.
To systematically identify candidate 18O fragment
patterns, a Python (2.5.2 ver.) program was written
and run against the collected data files. The program,
findIsoptopePatterns.py, takes as input an mzXML file
and outputs a tab delimited file listing candidate MS
and MS2 scans. First, the program identifies MS scans
that have produced one or more MS 2 scans. Then, for
each precursor value in the MS scan, the program looks
for an m/z value that is a fixed Da difference below the
precursor’s m/z (2  0.01 Da). In addition, the program
checks that the intensity value is a fixed percentage of the
precursor’s intensity (20%–80%). Second, the program
examines the MS2 peak list identifying 18O ion quartets.
Peaks in the quartet must be separated by a set Da
distance (1  0.3 Da). This distance, and tolerance, can be
set as a program parameter. The intensities for each of the
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value. To be considered a legitimate candidate pattern, the
first peak’s intensity must be within a minimum and
maximum percentage of the third peak (20%–80%). These
threshold values are modifiable parameters. To avoid the
higher propensity of detecting false patterns in the lower
m/z range, the program only counts and reports the
number of candidate fragment patterns above the precur-
sor m/z for each MS2 scan, as well as the MS pattern
discovered in the first step.
Results and Discussion
Targeted 18O-labeling of Protein Carbonyls
Our method induces the partial incorporation of 18O
into reactive carbonyls on peptides by hydrating the
Figure 1. Targeted labeling of carbonylated p
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guishable from any other naturally occurring peptide
isotope distributions observed within the typical m/z
range used for tandem mass spectrometry experiments.
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aqueous solvents, overcoming a limitation of past at-
tempts to use 18O-labeling of carbonylated peptides
[21]. Thus, the resulting 18O isotope signatures pro-
duced in the MS and MS2 spectra are diagnostic of
carbonylated peptides and provide additional depth of
information from these spectra. A caveat of this method
is that carbonyls either involved in crosslinks or lost
due to retro Michael-addition chemistry are not subject
to analysis [22].
To demonstrate the effectiveness of our 18O-labeling
procedure, a digest of HNE-modified myoglobin was
incubated in 70% H2
18O for 2 h followed by reduction
in 10 mM sodium borohydride for an additional hour.
The resulting MS spectrum for the entire digest,
together with the magnified isotope envelopes for the
nonmodified and HNE-modified forms of the peptide
VEADIAGHGQEVLIR are presented in Figure 1b. The
specific partial incorporation of 18O into the HNE-
modified form of the peptide produced a unique iso-
tope signature, characterized by a 2 Da isotopologue
that measured about twice the intensity of the monoiso-
topic ion, making it readily distinguishable from the
non-modified form (Figure 1b). Importantly, this iso-
tope signature was retained in the MS2 spectrum for
fragments that carry the carbonyl modification, and
thus provides a tool for validating database search
results (Figure 1c). Both the presence of a carbonyl
modification and the exact residue to which the car-
bonyl is localized can be determined. This concept is
demonstrated in the MS2 spectrum generated by the
aforementioned HNE-modified peptide where frag-
ments from the nonmodified portion of the peptide
(e.g., y1 and y7) show normal isotope signatures,
while those from HNE-modified fragments (e.g., y11
and the His immonium ion) show the distinctive 18O
isotope signature (Figure 1c, insets). The presence of
these spectral features unique to carbonylated peptides
enables independent validation of database search re-
sults on MS2 spectra, confirming both the presence and
localization of reactive carbonyl modifications within
the matched peptide.
Eliminating Trypsin-Catalyzed 18O Exchange
Although the proof-of-principle results in Figure 1 were
encouraging, a significant potential problem existed.
This problem results from the well-described protease-
catalyzed exchange of carboxyl oxygens from the C-
termini of peptides with those from the solvent [23].
Although useful for global quantitative proteomic stud-
ies [24, 25], for our purposes the potential partial
incorporation of 18O into the carboxy terminus of all
peptides would result in all tryptic peptides with a free
C-terminal carboxyl group being mass tagged, and
hamper our attempts to limit such tags specifically to
peptides carrying reactive carbonyl modifications. To
address this issue, we compared the efficacy of several
measures [26–28] to eliminate the oxygen-exchangeactivity of trypsin within a digest of HNE-modified
myoglobin, using 18O incorporation as the readout
(Figure 2). For these experiments, non-HNE modified
myoglobin peptides 18O labeled at their C-termini were
detected by the presence of at least one 18O isotopo-
logue in the MS spectra resulting in a mass shift of 2 Da
or more. Meanwhile, HNE-modified myoglobin peptides
18O-labeled at both the reactive carbonyl and C-termini
were detected by the presence of at least two 18O isotopo-
logues, resulting in a mass shift of 4 Da or more.
In the absence of any measures to inactivate trypsin,
the C-termini of both nonmodified and HNE-modified
peptides were labeled with multiple 18O molecules such
that the isotope signatures remained indistinguishable
(Figure 2a). Efforts to physically remove trypsin by
ultrafiltration almost completely abolished the incorpora-
tion of 18O into peptide C-termini (Figure 2b), and while
promising, concerns about the reliability and possible
sample loss of ultrafiltration devices have been docu-
mented [27, 28]. Alternatively, Hajkova and colleagues
recently characterized the pH dependency observed for
the oxygen-exchange activity of trypsin and found a
substantial loss of function at more basic conditions [26].
Based on their findings, we attempted to prevent 18O
incorporation into the peptide C-termini by shifting the
pH of the 18O-labeling reaction to 12, which only partially
reduced the incorporation of 18O into the C-terminus of
peptides (Figure 2c). Another method for inactivating
trypsin described by Smith and colleagues involves
boiling the samples [27, 29, 30]. However, in our hands,
boiling the HNE-myoglobin digest before 18O-labeling
did not significantly reduce 18O incorporation into
the C-terminus of peptides, presumably due to re-
folding of the enzyme back into its catalytically active
state during the subsequent two-hour 18O-labeling
reaction (Figure 2d).
Given the observed limitations of the measures
above, we pursued an alternative approach which
sought to exploit trypsin’s ability to back-exchange the
C-terminus. By adding an additional step whereby the
reduced peptides were incubated in 100% 16O water
supplemented with trypsin, we hypothesized that the
trypsin would completely incorporate 16O back into the
C-terminus, while leaving the 18O trapped in the re-
duced HNE modification unaffected. Indeed, after an
overnight incubation virtually all peptides were free of
18O incorporation into their C-terminus, while the sig-
nature isotope pattern for HNE-modified peptides was
preserved (Figure 2e). Given the effectiveness of this
simple procedure to remove 18O incorporated into the
peptide C-termini of reduced peptides, we decided to
incorporate it into our overall method for characterizing
carbonylated peptides. Importantly, the results from
these studies demonstrated our ability to limit 18O
incorporation to the oxygen of the reactive carbonyl,
ensuring that the corresponding isotope signatures de-
tected by mass spectrometry were specific to carbony-
lated peptides.
over
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the Analysis of Carbonylated Peptides from
Complex Mixtures
To characterize the carbonyl proteome in complex mix-
tures, we previously described a front-end enrichment
method based on the reversible, covalent capture and
release of carbonylated peptides to an SPH reagent [20].
Here we sought to combine SPH enrichment and 18O-
labeling to develop an integrated method for enhancing
the detection and identification of carbonylated pep-
tides from complex mixtures. This method integrates
three stages: (1) enrichment of carbonylated peptides;
Figure 2. Comparison of methods for eliminati
of HNE-modified myoglobin was incubated w
methods for preventing the trypsin-catalyzed in
C-terminus of peptides. The isotope envelope
nonmodified and HNE-modified (#) form as obs
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18O-labeled (70%) and reduced. (c) The digest w
to inactivate trypsin’s oxygen-exchange activity
trypsin and then labeled with 70% 18O. (e) T
intervening measures for inactivating trypsin, v
16O water supplemented trypsin, and incubated(2) 18O-labeling of enriched peptides; and (3) analysis oflabeled peptides by high-resolution mass spectrometry
(Figure 3). In the first stage, the SPH reagent, described
in detail in the Materials andMethods section, is used to
enrich carbonyl modified peptides from a complex
mixture, in this case HNE-modified peptides from a rat
skeletal muscle lysate. As we have previously described
[20], HNE-modified peptides are covalently bound to
the resin by formation of acid labile, covalent Schiff-
base bonds. As such, both peptide capture and subse-
quent wash steps were conducted at neutral pH,
wherein the Schiff-base bond is stable, while the elution
of the bound peptides was performed under acidic
e oxygen-exchange activity of trypsin. A digest
0% H2
18O (aqueous) after exposure to various
oration of 18O into the carboxyl oxygens at the
a single peptide from the digest, in both its
in a MALDI-TOF MS spectrum, are presented.
duced without any intervening measures for
ved by ultrafiltration, and the flow-through was
-labeled (70%) and reduced at a pH of 12 so as
The digest was boiled for 15 min to inactivate
igest was labeled with 70% 18O without any
centrifuged to dryness, reconstituted in 100%
night at room temperature.ng th
ith 7
corp
s for
erved
d re
emo
as 18O
. (d)
he d
acuumconditions. In the second stage, the enriched peptides
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18O at neutral pH, reduced with
sodium borohydride, and subjected to conditions promot-
ing the trypsin-catalyzed removal of any 18O incorporated
into the C-terminus of peptides during the labeling reac-
tion. Finally, the 18O-labeled sample is analyzed on an
LTQ-Orbitrap mass spectrometer to ensure sufficient res-
olution of the 16O:18O isotope signature of the carbony-
lated peptide precursor-ions, and to generate high quality
MS2 spectra using the linear ion trap.
Analysis of HNE-Treated Tissue Lysates from Rat
Skeletal Muscle
To test the value of this integrated method, we applied
it to the analysis of a rat skeletal muscle tissue lysate
treated with HNE. We first sought to confirm that 18O
labeling did not negatively affect our ability to identify
HNE-modified peptides by MS2 and database search-
ing. By comparing database matches from the same
SPH enriched sample split into a non-labeled (normal
16O isotope signatures) fraction, and a 18O-labeled frac-
tion, we found that the presence of 18O isotopologues in
the MS and MS2 spectra does not impair the ability of
sequence database searching to identify these peptides.
In fact, the 18O-labeled fraction resulted in a slight
increase in confident matches to HNE-modified pep-
tides than did the non-18O labeled fraction (Supplemen-
tal Figure 1, which can be found in the electronic
version of this article). Importantly, the two fractions
contained a similar number of collected MS2 spectra
and the same delta mass threshold was used in deter-
mining correct sequence matches for each dataset (see
the Materials andMethods section). The slight improve-
ment in the number of identifications for the 18O-
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Materials and Methods section.labeled sample may be due to the increased numberpeaks derived from the 18O isotope signatures available
for selection for MS2. Regardless, these results proved
that labeling with 18O did not negatively affect the
ability to identify HNE-modified peptides via MS2 and
database searching, a crucial point to demonstrating the
benefits of our method.
In total, 210 MS2 spectra from the 18O-labeled sample
were matched to 60 unique HNE-modified peptides
(Supplemental Table 1) at an estimated false positive
rate of 0% for matched peptides using stringent filtering
of matches (see the Materials and Methods section).
That the vast majority of peptides were modified at
histidine residues, with very few modifications at cys-
teine or lysine residues, is consistent with previous in
vitro modification studies [20, 31, 32], and is likely an
artifact of the in vitro treatment conditions, rather than
a bias towards histidine-modified peptides introduced
by the SPH or 18O-labeling procedures. In the present
study after 18O-labeling we did identify a few lysine
modified peptides (Supplemental Table 1), similar in
proportion to histidine-modified peptides to our previ-
ous description of the SPH reagent [20]. Therefore, SPH
and 18O-labeling is amenable to peptides modified at
residues other than histidine. As with any in vitro
treatment, it is difficult to know whether the modifica-
tions identified are conserved in the in vivo environ-
ment. However, for the purposes of the objectives of the
work described here, the in vitro treatment enabled us
to effectively demonstrate the utility of combining 18O-
labeling with label-free enrichment of carbonylated
peptides for analysis of complex mixtures of carbony-
lated proteins.
One advantage of this combined method is that
added information gained from 18O-labeling can be
ed Parally 18O-labeled,
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1198 ROE ET AL. J Am Soc Mass Spectrom 2010, 21, 1190–1203ple, the MS and MS2 spectra in Figure 4 were matched
by SEQUEST to a HNE-modified peptide from tropo-
myosin 1. The presence of an HNE-modification on the
peptide is first supported by the isotope signature of the
precursor ion where the monoisotopic and the 2
isotope appear in the expected 1:2 16O:18O ratio, specific
to HNE-modified peptides (Figure 4a). The preserva-
tion of the signature isotope pattern for multiple frag-
ment ions in the MS2 spectrum indicates that both the
16O and 18O precursor ions entered the collision cell
when using a 2.0 Da isolation width, which proved
convenient for confirming the accuracy of the peptide
sequence match and site of modification (Figure 4b, see
Supplemental Figure 2 for .out file). Importantly, all the
fragment ions with the expected 18O isotope signatures
were assigned to b-ions carrying the HNE modification,
while all the y-ions, which lacked the HNE modifica-
tion, were assigned to fragment ions with typical,
16O-only isotope signatures (Figure 4b, insets). The 18O
Figure 4. Example MS and MS2 spectra collecte
HNE-modified peptide from a rat muscle pro
signature isotope pattern produced by partia
precursor-ion of a carbonylated peptide. The
18O-labeled versions of the peptide, respectivel
ratio. (b) MS2 spectrum generated by fragment
linear ion trap using an isolation width of 2 Da
immonium ion, are labeled in the spectrum an
envelopes for several of the fragment ions have
As predicted by the sequence, the y-ion series d
b-ions, as well as the His immonium ion, do. *H
signatures.isotope signature was also observed for the HNE-modified immonium ion of His, further validating that
the modification was mapped to the correct residue
(Figure 4b, inset). Thus, greater confidence can be
gained for carbonylated peptides identified by database
matching as a result of 18O-labeling.
As observed with other peptide enrichment methods
[33], it was very difficult to completely remove non-
modified peptides that bind the resin nonspecifically. In
this case, such peptides provided a good internal con-
trol for evaluating the specificity of the 18O-labeling.
One such example (Supplemental Figure 3) was a
confidently matched non-HNE-modified peptide from
the protein actinin. As predicted, neither the MS nor the
MS2 spectrum contained isotope signatures reflective of
18O incorporation, indicating the specificity of our
method for incorporating 18O within the reactive car-
bonyl groups.
In addition to the numerous true positive matches
confirmed by 18O-labeling, a significant number of false
an LTQ-Orbitrap that matched confidently to a
tropomyosin 1. (a) MS spectrum showing the
corporation of 18O into the doubly charged
8 and 543.79 m/z ions represent the 16O and
ich appear in the expected relative abundance
he 18O-labeled isotopologue (543.79 m/z) in the
observed b- and y-ions, together with the His
own in bold in the peptide map. The isotope
magnified and are inlayed above the spectrum.
ot contain 18O isotopologues while the series of
abeled fragments expected to show 18O isotoped on
tein,
l in
542.7
y, wh
ing t
. The
d sh
been
oes n
NE lnegative matches were also identified by virtue of the
res.
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MS and MS2 spectra. A false negative match in this
context is an MS/MS spectrum derived from an HNE-
modified peptide incorrectly matched, albeit with
high confidence, to a non-HNE-modified peptide
sequence by the database searching program. For
example, although the MS and MS2 spectra in Figure 5
clearly contain 18O isotopologues, they were incorrectly
matched to a nonmodified peptide in the database
search. However, further scrutiny of the top 20 candi-
date peptide sequences matched to this MS2 spectrum
using SEQUEST revealed a candidate HNE-modified
peptide from myosin, an abundant protein in skeletal
muscle, which was the 12th best possible match (Sup-
plemental Figure 4). Upon inspection, the expected
series of b- and y-ions of this sequence matched nicely
to the major fragment ions in the spectrum (Figure 5b).
In addition, those fragment ions containing 18O isotope
signatures matched to b- and y-ions carrying the HNE
modification, while b- and y-ions matching to nonmodi-
fied fragment ions also lacked the 18O isotope signa-
tures. This is most clearly demonstrated when compar-
ing the nonmodified y4 ion, to the HNE-modified y5
ion (Figure 5b, inset). Indeed, the agreement between
Figure 5. Utility of 18O-labeling for identifyin
dence and ranked low in the SEQUEST output fil
a peptide incorrectly matched to a nonmodified
The clear presence of 18O isotopologues in both
lead ultimately to the correct identification of the
fragments expected to show 18O isotope signatu18O-labeled ions and expected HNE-modified fragmentions in this spectrum, together with the prominence of
myosin in skeletal muscle point to very likely being the
true match. Thus, the 18O-labeling method also comple-
ments results from sequence database searching, reveal-
ing additional MS2 spectra of modified peptides missed
by the search algorithm.
Based on the false negative peptide match described
above, and our past observations revealing many MS2
spectra generated from suspected HNE-modified pep-
tides were not being identified as such by sequence
database searching, we sought to further evaluate the
efficiency of sequence database searching of MS2 spec-
tra to identify modified peptides using 18O incorpora-
tion. Upon manual inspection of the LC run for the
HNE-labeled rat skeletal muscle sample, it was clear
that there were many more 18O isotope signatures for
peptide precursors selected for MS2 than were not
identified by database searching. As an example, a
representative MS spectrum is shown in Supplemental
Figure 5. In addition to ions with typical isotope pat-
terns (corresponding to nonspecifically bound back-
ground peptides), many more with atypical 18O isotope
signatures indicative of HNE-modified peptides were
observed, as detailed in this figure. Of the nine isotope
E-modified peptides matched with low confi-
e MS (a) and subsequent MS2 spectrum (b) from
de in the reverse database (i.e., a false negative).
ra guided further scrutiny of the output file and
E-modified peptide from myosin. *HNE labeledg HN
e. Th
pepti
spect
HNsignatures consistent with 18O labeling, three were not
1200 ROE ET AL. J Am Soc Mass Spectrom 2010, 21, 1190–1203selected for MS2, and of the six selected for MS2 only
one was confidently matched to an HNE-modified
peptide. These findings suggested that MS2 combined
with sequence database searching performed relatively
poorly at identifying HNE-modified peptides.
Given our observations above based on a manual
analysis of representative data, we sought to make use
of the information provided by 18O labeling and inves-
tigate more systematically our ability to identify HNE-
modified peptides via MS2 and sequence database
searching. For this, we created software that automati-
cally interrogates mzXML-formatted LC-MS/MS data
in search of unique isotope signatures attributable to
partial 18O incorporation at reactive carbonyls. The
software identified ion clusters in MS and MS2 spectra
that adhered to strict m/z spacing and relative abun-
dance constraints expected for 18O-labeled peptide iso-
topologues (described in detail in the Materials and
Methods section).
We evaluated the specificity of our software for
detecting 18O isotope signatures by applying the soft-
ware to a non-18O-labeled, negative control sample.
This negative control sample was a portion of the same
enriched, HNE-modified peptides derived from the rat
muscle homogenate used for testing our 18O incorpora-
tion method, except the 18O-labeling was omitted. The
negative control sample was analyzed using the same
LC-MS/MS method on the LTQ-Orbitrap as was the
18O-labeled sample, expecting that detected peptides
from the negative control should show “normal” 16O
isotope signatures, and would thus not be detected by
our software.
For our analysis, we focused on only those peptides
selected for MS2 throughout our chromatographic run.
We started with relaxed criteria, requiring our software
to detect an 18O isotope signature in the MS spectrum,
and only one 18O isotope signature in the resulting MS2
spectrum. Using these relaxed criteria, we estimated a
false-positive rate (FPR) of 8.5% for detecting 18O la-
beled HNE-modified peptides (Table 1). As a point of
Table 1. Measuring the false positive rate (FPR) for
identification of 18O-labeled MS2 spectra by our software
Minimum no. of
18O-labeled fragment
ions in MS2
spectrum
No. of MS2 spectra
determined by software
to be 18O-labeled
FPR*
(%)
18O-labeled
sample
Non-18O labeled
control
1 1002 85 8.5
3 336 7 2.1
*The FPR of 18O labeled peptides identified by our software was
measured by dividing the number of 18O-labeled MS2 spectra from the
non-18O-labeled control by the number identified in the 18O-labeled
sample. While requiring that the precursor-ion appears as an 18O
isotope signature, increasing the minimum number of 18O isotope
signatures in the MS2 spectra used by the software to identify 18O-
labeled MS2 spectra from one (relaxed) to three (stringent) product ions
18reduces the FPR to acceptable levels. O isotope signatures are defined
in the text.clarification, this estimated FPR refers to the ability of
our software program to identify peptides carrying 18O
isotope signatures within MS or MS2 spectra, and not
the FPR relating to peptide sequence matches obtained
by sequence database searching. This FPR estimation
was because for a comparable number of total MS2
scans (8500 MS2 scans) 85 negative control MS2 spec-
tra were identified by our software as being 18O isotope
labeled compared with 1002 from the 18O-labeled sam-
ple. Therefore, we estimated that 85 of the 1002 MS2
spectra (8.5%) from the sample were also false positives.
To lower the FPR and generate a more conservative
estimate of the number of 18O-labeled spectra in the
dataset, we tightened the criteria the software uses to
identify 18O-labeled spectra by requiring that all accept-
able MS2 spectra contain a minimum of three fragment
ions with 18O isotope signatures. These more stringent
criteria produced seven and 336 MS2 spectra from the
negative control and 18O-labeled sample, respectively,
which corresponds to a FPR of 2.1%, and demonstrates
the specificity of our software program for detecting
18O-labeled, carbonylated peptides.
To evaluate the efficiency by which HNE-modified
peptides are identified by database searching of MS2
spectra, we compared the MS2 spectra matched to
HNE-peptides by sequence database searching with
those identified by the software as being 18O-labeled.
Comparison of the database matched spectra against
those deemed 18O-labeled using the relaxed software
criteria revealed significant overlap (Figure 6a). This
indicates that 18O-labeling complements the use of MS2
and database searching to detecting additional HNE-
modified peptides from the mass spectrometry data.
Assuming the total combined spectra (both those con-
fidently matched to peptides by MS2 and database
searching and those additional spectra identified by our
software) provide an estimate of the “true” number of
MS2 spectra derived from carbonylated peptides, the
efficiency by which database searching matched MS2
spectra to carbonylated peptides in our sample was
estimated to be 20% (210 total database matched
spectra/1074 total combined spectra). It should be
noted that this dataset includes a relatively high.
FPR (8.5%) for the detection of 18O-labeled spectra by
our software, indicating that the remaining 864 spectra
in the dataset is a slight overestimation of the number of
18O-labeled MS2 spectra missed by the database search,
and thus 20% probably slightly underestimates the
database search efficiency.
A more conservative measure of database searching
of MS2 spectra performance was achieved by compar-
ing the MS2 spectra matched to HNE-modified peptides
against the 18O-labeled MS2 spectra identified using the
more stringent criteria (Figure 6b and Supplemental
Table 2). Compared to the number of proteins identified
by our software using the relaxed criteria (Figure 6a),
the more stringent criteria excluded a significant num-
ber of database matched HNE-modified peptides that
were marked as 18O-labeled using the relaxed criteria.
1201J Am Soc Mass Spectrom 2010, 21, 1190–1203 TARGETED 18O-LABELING OF CARBONYLATED PEPTIDESInterestingly, the MS2 spectra from peptide ions with
charge states of three and higher were disproportion-
ately omitted from the resulting dataset following ap-
plication of these stricter criteria (Supplemental Table
3). One reason for this bias may be the presence of
multiply charged fragment ions in the MS2 spectra,
whose 18O isotope signatures are not well resolved in
the low-resolution LTQ ion trap. Regardless of the
reason, the 261 proteins indicated in Figure 6b most
likely underestimates the true number of MS2 spectra
from HNE-modified peptides that were identified as
18O-labeled by our software, but missed by the database
search. As such, the resulting efficiency of database
search performance of 45% (210 total database matched
spectra/471 total combined spectra) likely overesti-
mates the true value.
Given the confident identification of somewhere
between 20% and 45% of HNE-peptides selected for
MS2, two questions arise: what limits the identification
of these modified peptides, and how can it be im-
proved? One potential limiting factor may be unex-
pected fragmentation of the HNE group from both
precursor and fragment ions, which could complicate
analysis. Distinct from neutral-loss, such ill-defined
fragmentations are beyond the scope of this study and
warrant further investigation. Another possible limiting
factor is that the 18O isotope signature observed for
some peptides may result from the incorporation of 18O
into the C-terminus of peptides, despite our efforts to
prevent this. However, we discounted this possibility
by including in the database search a differential mass
shift on the peptide C-terminus that accounts for 18O
incorporation, which showed a negligible number of
matches to C-terminal modified peptides (data not
shown). The presence of other modifications on HNE-
modified peptides (e.g. oxidations) not accounted for in
the sequence database search may also contribute to the
Figure 6. Comparison of HNE-modified MS2 sp
18O-labeled MS2 spectra from 18O-labeled sampl
via sequence database searching were compare
software using either relaxed (a), or stringent (b
the text.low efficiency of identifications. Along with these pos-sible additional modifications, the potential for un-
known chemical modifications introduced by reducing
the sample with sodium borohydride may also be of
concern. However, proof-of-principle studies on our
standard protein indicated that unexpected peaks re-
sulting from additional modifications do not appear
following reduction.
Several avenues of study may improve our ability to
identify HNE and other carbonyl-modified peptides.
Studies directed towards defining possible unconven-
tional CID fragmentation patterns unique to HNE and
other reactive carbonyls would be highly valuable.
Alternatively, fragmentation of carbonylated peptides
by “softer” methods (ETD and ECD) may provide a
way to preserve the fragmented peptide in its modified
form, thus decreasing the complexity of the spectra and
presumably increasing the efficiency by which correct
identifications are made. Indeed, a recent study has
coupled our SPH enrichment method with ECD analy-
sis, showing the promise of alternative fragmentation
methods for analysis of HNE-modified peptides [34].
Investigations into the relative effectiveness of instru-
ments other than the LTQ-Orbitrap (e.g., MALDI-TOF/
TOF) instruments may also illuminate instrument-
specific differences. Notably, our 18O method should
provide a valuable tool for these future studies seeking
a better understanding of the factors mediating the
identification of carbonyl-modified peptides using MS2
and sequence database searching.
Conclusions
We have described a new method for improving the
detection and identification of carbonylated peptides by
mass spectrometry based on partial 18O-labeling, add-
ing a valuable tool for redox proteomics. We have
shown the effectiveness of this method for confirming
identified via sequence database searching and
2 spectra confidently matched to HNE-peptides
inst 18O-labeled MS2 spectra identified by our
eria. Details of the criteria used are provided inectra
e. MS
d aga
) critHNE-modified peptides matched by sequence database
1202 ROE ET AL. J Am Soc Mass Spectrom 2010, 21, 1190–1203searching, for identifying false negative matches, and
for detecting modified peptides not selected for MS2
fragmentation. Compared with other diagnostic ions
used to screen for carbonylated peptides, 18O-labeling
should enjoy greater applicability and provide more
information. For example, unlike the immonium ion for
His HNE-adducts (266 m/z), or the dehydrated product
of HNE (139 m/z) often observed for HNE-modified
peptides [20, 35], the 18O isotope signatures are not
limited to a specific adduct of a given reactive carbonyl,
nor even to a single class of reactive carbonyls. Al-
though still needing empirical confirmation, our
method should therefore aid in proteomic studies span-
ning the wide variety of modifications that encompass
protein carbonylation. One potential concern of this
partial isotope labeling approach is that it effectively
divides signal intensity across two ions, which may
prove limiting when analyzing in vivo samples. How-
ever, this problem could be addressed by developing a
directed acquisition of MS2 data that targets only the
most intense ion within 18O isotope signatures. Finally,
our software developed for the systematic identification
of 18O-labeled peptides should have value for investi-
gators undertaking proteomic studies of carbonylation,
for example as it relates to aging and disease progres-
sion, and for those seeking to better understand and
improve the characterization of carbonylated peptides
using mass spectrometry. It operates on the open-
source mzXML file format, making it compatible with
all mass spectrometers offering high mass accuracy
and resolution. The software and code is available on
request.
Acknowledgments
The authors thank the Center for Mass Spectrometry and Proteom-
ics at the University of Minnesota for instrument access and
maintenance, in particular Matt Stone for his assistance with
operation of the LTQ-Orbitrap. They also thank the Minnesota
Supercomputing Institute for maintenance and administration of
the SEQUEST cluster and related software. The authors acknowl-
edge funding in part for this work by grant NIA AG017768
(L.V.T.).
Appendix A
Supplementary Material
Supplementary material associated with this article
may be found in the online version at doi:10.1016/
j.jasms.2010.03.029.
References
1. Dalle-Donne, I.; Giustarini, D.; Colombo, R.; Rossi, R.; Milzani, A.
Protein Carbonylation in Human Diseases. Trends Mol. Med. 2003, 9,
169–176.
2. Grimsrud, P. A.; Xie, H.; Griffin, T. J.; Bernlohr, D. A. Oxidative Stress
and Covalent Modification of Protein with Bioactive Aldehydes. J. Biol.
Chem. 2008, 283, 21837–21841.
3. Dalle-Donne, I.; Scaloni, A.; Giustarini, D.; Cavarra, E.; Tell, G.; Lun-
garella, G.; Colombo, R.; Rossi, R.; Milzani, A. Proteins as Biomarkers of
Oxidative/Nitrosative Stress in Diseases: The Contribution of Redox
Proteomics. Mass Spectrom. Rev. 2005, 24, 55–99.4. Berlett, B. S.; Stadtman, E. R. Protein Oxidation in Aging, Disease, and
Oxidative Stress. J. Biol. Chem. 1997, 272, 20313–20316.
5. Requena, J. R.; Chao, C. C.; Levine, R. L.; Stadtman, E. R. Glutamic and
Aminoadipic Semialdehydes are the Main Carbonyl Products of Metal-
Catalyzed Oxidation of Proteins. Proc. Natl. Acad. Sci. U.S.A. 2001, 98,
69–74.
6. Chevion, M.; Berenshtein, E.; Stadtman, E. R. Human Studies Related to
Protein Oxidation: Protein Carbonyl Content as a Marker of Damage.
Free Radical Res. 2000, 33(Suppl.), S99–S108.
7. Monnier, V. M. Nonenzymatic Glycosylation, the Maillard Reaction,
and the Aging Process. J. Gerontol. 1990, 45, B105–B111.
8. Sies, H. Role of Reactive Oxygen Species in Biological Processes. Klin.
Wochenschr. 1991, 69, 965–968.
9. Carini, M.; Aldini, G.; Facino, R. M. Mass Spectrometry for Detection of
4-Hydroxy-trans-2-Nonenal (HNE) Adducts with Peptides and Pro-
teins. Mass Spectrom. Rev. 2004, 23, 281–305.
10. Mirzaei, H.; Baena, B.; Barbas, C.; Regnier, F. Identification of Oxidized
Proteins in Rat Plasma Using Avidin Chromatography and Tandem
Mass Spectrometry. Proteomics 2008, 8, 1516–1527.
11. Grimsrud, P. A.; Picklo, M. J., Sr.; Griffin, T. J.; Bernlohr, D. A.
Carbonylation of Adipose Proteins in Obesity and Insulin Resistance:
Identification of Adipocyte Fatty Acid-Binding Protein as a Cellular
Target of 4-Hydroxynonenal. Mol. Cell. Proteom. 2007, 6, 624–637.
12. Mirzaei, H.; Regnier, F. Affinity Chromatographic Selection of Carbony-
lated Proteins Followed by Identification of Oxidation Sites Using
Tandem Mass Spectrometry. Anal. Chem. 2005, 77, 2386–2392.
13. Soreghan, B. A.; Yang, F.; Thomas, S. N.; Hsu, J.; Yang, A. J. High-
Throughput Proteomic-Based Identification of Oxidatively Induced
Protein Carbonylation in Mouse Brain. Pharm. Res. 2003, 20, 1713–1720.
14. Meany, D. L.; Xie, H.; Thompson, L. V.; Arriaga, E. A.; Griffin, T. J.
Identification of Carbonylated Proteins from Enriched Rat Skeletal
Muscle Mitochondria Using Affinity Chromatography-Stable Isotope
Labeling and Tandem Mass Spectrometry. Proteomics 2007, 7, 1150–
1163.
15. Codreanu, S. G.; Zhang, B.; Sobecki, S. M.; Billheimer, D. D.; Liebler,
D. C. Global Analysis of Protein Damage by the Lipid Electrophile
4-Hydroxy-2-nNonenal. Mol. Cell. Proteom. 2009, 8, 670–680.
16. Thomas, S. N.; Soreghan, B. A.; Nistor, M.; Sarsoza, F.; Head, E.; Yang,
A. J. Reduced Neuronal Expression of Synaptic Transmission Modula-
tor HNK-1/Neural Cell Adhesion Molecule as a Potential Consequence
of Amyloid -Mediated Oxidative Stress: A Proteomic Approach.
J. Neurochem. 2005, 92, 705–717.
17. Yi, E. C.; Li, X. J.; Cooke, K.; Lee, H.; Raught, B.; Page, A.; Aneliunas, V.;
Hieter, P.; Goodlett, D. R.; Aebersold, R. Increased Quantitative Pro-
teome Coverage with (13)C/(12)C-Based, Acid-Cleavable Isotope-
Coded Affinity Tag Reagent and Modified Data Acquisition Scheme.
Proteomics 2005, 5, 380–387.
18. Chavez, J.; Wu, J.; Han, B.; Chung, W. G.; Maier, C. S. New Role for an
Old Probe: Affinity Labeling of Oxylipid Protein Conjugates by N=-
Amino-Oxymethylcarbonylhydrazino d-Biotin. Anal. Chem. 2006, 78,
6847–6854.
19. Han, B.; Stevens, J. F.; Maier, C. S. Design, Synthesis, and Application of
a Hydrazide-Functionalized Isotope-Coded Affinity Tag for the Quan-
tification of Oxylipid-Protein Conjugates. Anal. Chem. 2007, 79, 3342–
3354.
20. Roe, M. R.; Xie, H.; Bandhakavi, S.; Griffin, T. J. Proteomic Mapping of
4-Hydroxynonenal Protein Modification Sites by Solid-Phase Hydra-
zide Chemistry and Mass Spectrometry. Anal. Chem. 2007, 79, 3747–
3756.
21. Sun, G.; Anderson, V. E. A Strategy for Distinguishing Modified
Peptides Based on Post-Digestion 18O Labeling and Mass Spectrometry.
Rapid Commun. Mass Spectrom. 2005, 19, 2849–2856.
22. Ichihashi, K.; Osawa, T.; Toyokuni, S.; Uchida, K. Endogenous Forma-
tion of Protein Adducts with Carcinogenic Aldehydes. J. Biol. Chem.
2001, 276, 23903–23913.
23. Schnolzer, M.; Jedrzejewski, P.; Lehmann, W. D. Protease-catalyzed
Incorporation of 18O into Peptide Fragments and Its Application for
Protein Sequencing by Electrospray and Matrix-Assisted Laser
Desorption/Ionization Mass Spectrometry. Electrophoresis 1996, 17,
945–953.
24. Heller, M.; Mattou, H.; Menzel, C.; Yao, X. Trypsin Catalyzed 16O-to-
18O Exchange for Comparative Proteomics: TandemMass Spectrometry
Comparison Using MALDI-TOF, ESI-QTOF, and ESI-Ion Trap Mass
Spectrometers. J. Am. Soc. Mass Spectrom. 2003, 14, 704–718.
25. Yao, X.; Freas, A.; Ramirez, J.; Demirev, P. A.; Fenselau, C. Proteolytic
18O Labeling for Comparative Proteomics: Model Studies with Two
Serotypes of Adenovirus. Anal. Chem. 2001, 73, 2836–2842.
26. Hajkova, D.; Rao, K. C.; Miyagi, M. pH Dependency of the Carboxyl
Oxygen Exchange Reaction Catalyzed by Lysyl Endopeptidase and
Trypsin. J. Proteome Res. 2006, 5, 1667–1673.
27. Petritis, B.; Qian, W. J.; Camp, D.; Smith, R. A Simple Procedure for
Effective Quenching of Trypsin Activity and Prevention of 18O-Labeling
Back-Exchange. J. Proteome Res. 2009, 8, 2157–2163.
28. Sevinsky, J. R.; Brown, K. J.; Cargile, B. J.; Bundy, J. L.; Stephenson, J. L.
Jr. Minimizing back exchange in 18O/16O Quantitative Proteomics
Experiments by Incorporation of Immobilized Trypsin into the Initial
Digestion Step. Anal. Chem. 2007, 79, 2158–2162.29. Liu, T.; Qian, W. J.; Strittmatter, E. F.; Camp, D. G. II; Anderson, G. A.;
Thrall, B. D.; Smith, R. D. High-Throughput Comparative Proteome
1203J Am Soc Mass Spectrom 2010, 21, 1190–1203 TARGETED 18O-LABELING OF CARBONYLATED PEPTIDESAnalysis Using a Quantitative Cysteinyl-Peptide Enrichment Tech-
nology. Anal. Chem. 2004, 76, 5345–5353.
30. Qian, W. J.; Monroe, M. E.; Liu, T.; Jacobs, J. M.; Anderson, G. A.; Shen,
Y.; Moore, R. J.; Anderson, D. J.; Zhang, R.; Calvano, S. E.; Lowry, S. F.;
Xiao, W.; Moldawer, L. L.; Davis, R. W.; Tompkins, R. G.; Camp, D. G.
2nd; Smith, R. D. Quantitative Proteome Analysis of Human Plasma
Following In Vivo Lipopolysaccharide Administration Using 16O/18O
Labeling and the Accurate Mass and Time Tag Approach. Mol. Cell.
Proteom. 2005, 4, 700–709.
31. Fenaille, F.; Parisod, V.; Tabet, J. C.; Guy, P. A. Carbonylation of Milk
Powder Proteins as a Consequence of Processing Conditions. Proteomics
2005, 5, 3097–3104.32. Orioli, M.; Aldini, G.; Beretta, G.; Facino, R. M.; Carini, M. LC-ESI-
MS/MS Determination of 4-Hydroxy-trans-2-Nonenal Michael Adductswith Cysteine and Histidine-Containing Peptides as Early Markers of
Oxidative Stress in Excitable Tissues. J. Chromatogr. B Anal. Technol.
Biomed. Life Sci. 2005, 827, 109–118.
33. Ranish, J. A.; Yi, E. C.; Leslie, D. M.; Purvine, S. O.; Goodlett, D. R.; Eng,
J.; Aebersold, R. The Study of Macromolecular Complexes by Quanti-
tative Proteomics. Nat. Genet. 2003, 33, 349–355.
34. Rauniyar, N.; Stevens, S. M.; Prokai-Tatrai, K.; Prokai, L. Characterization
of 4-Hydroxy-2-Nonenal-Modified Peptides by Liquid Chromatography-
Tandem Mass Spectrometry Using Data-Dependent Acquisition: Neutral
Loss-Driven MS3 Versus Neutral Loss-Driven Electron Capture Dissocia-
tion. Anal. Chem. 2009, 81, 782–789.
35. Bolgar, M. S.; Gaskell, S. J. Determination of the Sites of 4-Hydroxy-2-
Nonenal Adduction to Protein by Electrospray TandemMass Spectrom-
etry. Anal. Chem. 1996, 68, 2325–2330.
